Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice

Aim: Recent studies have demonstrated that selective sodium–glucose cotransporter 2 inhibitors (SGLT2is) reduce cardiovascular events, although their mechanism remains obscure. We examined the effect of canagliflozin, an SGLT2i, on atherogenesis and investigated its underlying mechanism. Method: Can...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Atheroscler Thromb
Egile Nagusiak: Rahadian, Arief, Fukuda, Daiju, Salim, Hotimah Masdan, Yagi, Shusuke, Kusunose, Kenya, Yamada, Hirotsugu, Soeki, Takeshi, Sata, Masataka
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Japan Atherosclerosis Society 2020
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7803832/
https://ncbi.nlm.nih.gov/pubmed/32101837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.52100
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak